Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus

doi:10.5409/wjcp.v5.i1.75

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11054)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

1076

WORD

445

HTML

5137

Tables (1-2)

266

Sum=6924

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

468

Download

863

Sum=1331

Publishing Process of This Article

Item

Count

Browse

1088

Download

1711

Sum=2799

Feb 8, 2016 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Pediatr. Feb 8, 2016; 5(1): 75-81
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.75

Table 2 Comparison of adverse effects of oral ibuprofen and paracetamol[3]

	Oral ibuprofen	Oral paracetamol
Renal side effects	+/-	-
NEC	+	-
Spontaneous intestinal perforation	+	-
Gastrointestinal system bleeding	++	-
IVH	+	-
BPD	+/-	-
Alteration of platelet function	+	-
Decrease in cerebral blood flow	-	-
Hyperbilirubinemia	+/-	-
Hypertransaminasemia	-	+

NEC: Necrotizing enterocolitis; IVH: Intraventricular hemorrhage; BPD: Bronchopulmonary dysplasia.

Citation: Oncel MY, Erdeve O. Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World J Clin Pediatr 2016; 5(1): 75-81
URL: https://www.wjgnet.com/2219-2808/full/v5/i1/75.htm
DOI: https://dx.doi.org/10.5409/wjcp.v5.i1.75